Additionally, the CRP/albumin ratio has been demonstrated to have a prognostic value, in terms of overall survival, comparable to other inflammation-based prognostic scores, such as the Glasgow Prognostic Score, the modified Glasgow Prognostic Score, and the neutrophil/lymphocyte ratio, for patients with hepatocellular carcinoma [11, 36, 37]. This evidence concerns the gene ALB and hepatocellular carcinoma.